KAITLIN MOORE: Open Payments
NPI 1295158103 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 35 payments from 12 companies in 2025. Trend: 2023 $1,485 · 2024 $1,076 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $145 |
| BridgeBio Pharma, Inc. | 5 | $129 |
| Merck Sharp & Dohme LLC | 5 | $98 |
| Novo Nordisk Inc | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| PFIZER INC. | 4 | $74 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Amgen Inc. | 2 | $35 |
Products named: Attruby, MERLIN@HOME, VERQUVO, LEQVIO, LifeVest, JARDIANCE, VYNDAQEL, Wegovy.
Industry payments across TX — which companies pay providers there.
